Recent clinical studies indicate that high expression of Ptch1 and Gli1 is associated with larger tumors, metastasis, pathological progression and with significantly shorter OS and DFS in BC patients with CD44+/CD24− BCSC-enriched tumors [286]. The gene discussed is CD44; the disease is breast cancer.